AgeX Ther. / Reverse Bio – BAT1

AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. We are building upon the foundation of our proprietary technologies such as PureStem® and induced Tissue Regeneration (iTR™) to develop innovative medicines designed to address some of the largest unsolved problems in aging. Through PureStem® we have the ability to generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. iTR™ is our revolutionary longevity platform aiming to unlock cellular immortality and regenerative capacity to reverse age-related changes in the body. AGEX-BAT1 is AgeX Therapeutic’s preclinical cell therapy product candidate of brown adipocytes for the treatment of certain age-related metabolic disorders such as Type II diabetes. Dr. Michael West is the founder and CEO.